April Falcone Email Address

Senior Director, Global Brand and Marketing Communications

NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter Analysis System has been employed in life sciences research since it was first introduced in 2008 and has been cited in more than 800 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company's technology has also been applied to diagnostic use. The Prosigna Breast Cancer Prognostic Gene Signature Assay together with the nCounter Dx Analysis System is FDA 510(k) cleared for use as a prognostic indicator for distant recurrence of breast cancer.

Accomplished executive marketing and communications professional with proven abilities in strategic marketing and corporate communications for audiences worldwide. Colleagues describe me as collaborative and versatile with a “can do” attitude and sensible approach. I am adept at distilling complex information into clear and effective marketing strategies and communications for global organizations in highly regulated environments. A leader and manager with nearly 20 years’ experience in the marketing, communications and creative brand industries for companies spanning from non-profit organizations to big pharma. I am accomplished in strategizing and implementing internal and external global marketing and communications programs designed to promote positive brand and corporate image, optimize market opportunities, cultivate strategic relationships essential to revenue targets, and maintain stakeholder expectations.